Delivery Order SPE2DB20D3103-SPE2DB24FL6L5

Award Date 11/24/23
Potential Completion Date 11/27/23
Potential Value $2.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DX15D3021|SPE2DX23F1LE8, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,724.49 firm-fixed-price delivery order is for the supply of 90 tablets of the pharmaceutical drug Pirfenidone 267 mg. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,304.09 Firm Fixed Price Delivery Order is for the supply of 4566692516 Pirfenidone 801 mg tablets, a medication used to treat a specific medical condition. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,440.79, is for the delivery of 4566594653 - Pirfenidone 801 mg Tablets, 90-count, and does not have a set-aside designation. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,469.91 firm fixed-price delivery order is for the supply of 4564492478 - Pirfenidone 267 mg tablets. The contract has an ultimate completion date of May 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the...
This federal contract award, SPE2DX15D3014|SPE2DX24FXCYL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,231.59 firm fixed-price delivery order is for the supply of 4563731426 - Pirfenidone 801 mg Tablets. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,201.50 fixed-price delivery order is for the supply of Pirfenidone 267 mg tablets, a medication used to treat pulmonary fibrosis. The contract has an ultimate completion date of March 18, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,160,572 Pirfenidone 801 mg tablets in 90-count packages. The contract has a ceiling value of $2,971.38 and a period of performance through April 4, 2024. This award is a task order under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, with a potential value of up to...
This federal contract award, with the identifier SPE2DB20D3103|SPE2DB24FM5N8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,555,216 units of the prescription drug Pirfenidone 801 mg Tablet, with a ceiling value of $4,108.38. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement and has an ultimate completion date of February 6, 2024. The contract is not...
This federal contract award, valued at $102,116.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Pirfenidone 267 mg tablets, a medication used for the treatment of idiopathic pulmonary fibrosis. The contract has a completion date of February 13, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is the prime contractor...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 90-count tablets of the drug Pirfenidone 801 mg to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $4,288.85 and a completion date of June 26, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FL6L5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,160.10 fixed-price delivery order (SPE2DB20D3103|SPE2DB24FL6L5) is for the supply of Pirfenidone 267 mg tablets.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies in support of military and veteran healthcare programs globally. The contract has no set-aside designation, indicating full and open competition.

Generated 5/12/25, 9:56 AM